This Anti-Aging Drug is Disrupting a $600 Billion Industry
Dr. Alan Kaplin, Chief Scientific Officer of MyMD, joins Cheddar Innovates to discuss how the MYMD-1 is on track to be the first FDA-approved drug to treat aging and age-related diseases.
More Videos
Could Millennials be Saving Too Much?
An interesting savings trend has popped up among Millennials. Could they be saving TOO much money? Callie Cox at Ritholtz Wealth Management explains.
Are Employers Afraid to Hire Gen Z Workers?
GenZ workers get a bad rep when it comes to hiring - Why?Huy Nguyen, Chief Education and Career Development Advisor for Intelligent.com joins Cheddar to discuss
Is Election 2024 the "Crypto Election"?
The Crypto industry accounted for $170 million in donations, this election cycle alone. But why? Coinbase Chief Legal Officer, Paul Grewal, explains.
NAACP Launches $200 Million Fund: NAACP Capital
The NAACP has entered the VC space with a new fund that will invest in startups and fund managers that are focused on closing gaps facing communities of color.
Understanding Trump and Harris' Economic Policies
Cheddar's Dave Briggs and Peter Green unpack details on Trump and Harris' economic plans. Do people understand tariffs? Who will add more to the debt? Watch!
Rebounder Founders: Can your Layoff Lead to Your Next Big Thing?
Can a layoff lead to your next big thing? Issie Lapowsky, contributor for Inc. Magazine and Alphonzo Terrell, co-founder and CEO of Spill join us to discuss.
